Answer
No. It selectively activates peripheral kappa-opioid receptors to reduce itch and is not licensed as an analgesic.
Sources for this answer
- Kapruvia (Difelikalin) — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.